M. Esajas

Preferences and Experiences Regarding the Use of the Self-Sampling Device in hrHPV Screening for Cervical Cancer

E. Schuuring, K. Vermeulen, G. Wisman, 2021, The Patient - Patient-Centered Outcomes Research.

P53‐specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy

S. H. van der Burg, H. Hollema, R. Offringa, 2007, International journal of cancer.

Juvenile and adult vulvar pemphigoid, an under recognized entity: Case series of fourteen patients

M. Bolling, H. Pas, J. Oldhoff, 2021, JAAD case reports.

The Paget Trial: Topical 5% imiquimod cream for non-invasive vulvar Paget disease.

D. Boll, J. Bulten, M. van Beurden, 2022, American journal of obstetrics and gynecology.

Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.

H. Hollema, H. D. de Bruijn, A. V. D. Van Der Zee, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The use of hydroxychloroquine as a systemic treatment in erosive lichen planus of the vulva and vagina

J. Oldhoff, B. Horváth, M. Esajas, 2021, The British journal of dermatology.

Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme

E. Schuuring, G. Wisman, A. Bhattacharya, 2023, Clinical Epigenetics.

Methylation analysis to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening program.

G. Wisman, M. Esajas, M. de Boer, 2024, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.